Cover Image
市場調查報告書

藥物研發研究開發的西歐生物標記市場分析

Analysis of the Western European Biomarkers Market in Drug Discovery and Development

出版商 Frost & Sullivan 商品編碼 305718
出版日期 內容資訊 英文 153 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物研發研究開發的西歐生物標記市場分析 Analysis of the Western European Biomarkers Market in Drug Discovery and Development
出版日期: 2014年06月13日 內容資訊: 英文 153 Pages
簡介

生物標記試圖大幅改變醫療。生物標記在藥物研發的初期階段和臨床都日益大量使用,需求擴大。

本報告提供各種治療用途的生物標記的普及率、市場趨勢及市場動態帶來的影響相關分析、市場整體情況、市場分析的測量指標、收益預測,再加上主要企業的企業簡介,及重要的趨勢基因學、蛋白質體學、代謝體學,及成像、生物標記的各市場領域分析。

第1章 摘要整理

  • 調查結果的要點
  • 調查範圍及市場分類
  • 本報告的主要著眼點
  • 市場測量指標
  • CEO的觀點
  • 值得注意的主要企業
  • 各地區的市場魅力度
  • 三大預測

第2章 市場概況

  • 市場背景
  • 市場概要
  • 市場分類
  • 未來醫療趨勢

第3章 市場競爭情形分析

  • 新的市場機會
  • 企業吸收、合併,及企業聯盟的評估

第4章 推動市場成長要素及阻礙因素,及市場趨勢 - 藥物研發研究開發的生物標記整體市場

  • 推動市場成長要素
  • 阻礙市場成長要素
  • 推動因素及阻礙因素給予的影響

第5章 市場預測及未來趨勢 - 藥物研發研究開發的生物標記整體市場

  • 市場測量指標
  • 市場預測的前提條件
  • 收益預測
  • 各市場領域收益預測
  • 歐洲的生物標記市場預測
  • 各地區市場收益預測

第6章 新的趨勢

  • 技術趨勢
  • 市場趨勢
  • 新的趨勢
  • 技術生命週期分析

第7章 基因學領域市場分析

  • 市場測量指標
  • 收益預測
  • 基因學領域 - 定量的分析
  • 藥物研發及搭配診斷的基因學的市場成長機會分析

第8章 蛋白質體學領域市場分析

第9章 代謝體學領域市場分析

第10章 成像領域市場分析

第11章 生物標記研究團體

  • UK Biobank
  • The Biomarkers Consortium
  • 其他的研究計劃

第12章 地區市場分析

  • 各地區的市場魅力
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 斯堪地那維亞

第13章 值得注意的主要企業

第14章 結論

  • 三大預測

第15章 附錄

目錄
Product Code: MA01-01-00-00-00

Increasing Applications of Biomarkers are Driving Growth

Biomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends and dynamics are analysed in this study. This research service offers market overview, Market Engineering measurements, revenue forecasts, company profiling and key trends for the market and its segments, namely, genomics, proteomics, metabolomics and imaging biomarkers.

Key Questions This Study Will Answer

  • What are the key factors driving the market and the barriers that need to be resolved?
  • What is the current market scenario; How much growth is expected?
  • Which are the major market segments, and what are the important trends?
  • Which are the key market participants involved, and where do they stand?
  • What are the key application areas in biomarker research, and how will they impact the market in future?
  • What is the future of the market in Western Europe, and what should participants do to succeed?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Scope and Segmentation
  • 3. Key Questions This Study Will Answer
  • 4. Measurements
  • 5. CEO's Perspective
  • 6. Key Companies to Watch
  • 7. Market Attractiveness by Region
  • 8. 3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Market Overview
  • 3. Market Segmentation
  • 4. Market Segmentation (continued)
  • 5. Defining Future Healthcare Trends

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. Merger, Acquisition and Partnership Assessment
  • 4. Merger, Acquisition and Partnership Assessment (continued)

4. DRIVERS, RESTRAINTS AND TRENDS-TOTAL BIOMARKERS MARKET IN DRUG DISCOVERY AND DEVELOPMENT

Drivers, Restraints and Trends-Total Biomarkers Market in Drug Discovery and Development

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Impact Mapping of Drivers and Restraints

5. FORECAST AND TRENDS-TOTAL BIOMARKERS MARKET IN DRUG DISCOVERY AND DEVELOPMENT

Forecast and Trends-Total Biomarkers Market in Drug Discovery and Development

  • 1. Measurements
  • 2. Forecast Assumptions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Per cent Revenue Forecast by Segment
  • 6. Revenue Forecast by Segment
  • 7. Biomarkers Market Outlook in Europe
  • 8. Per cent Revenue by Region

6. EMERGING TRENDS

Emerging Trends

  • 1. Technology Trends
  • 2. Market Trends
  • 3. Emerging Trends
  • 4. Emerging Trends (continued)
  • 5. Emerging Trends (continued)
  • 6. Technology Lifecycle Analysis

7. GENOMICS SEGMENT BREAKDOWN

Genomics Segment Breakdown

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Revenue Forecast Discussion (continued)
  • 5. Genomics Segment-Metrics Analysis
  • 6. Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics
  • 7. Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics (continued)
  • 8. Growth Opportunity Analysis for Genomics in Drug Discovery and Companion Diagnostics (continued)

8. PROTEOMICS SEGMENT BREAKDOWN

Proteomics Segment Breakdown

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Proteomics Segment-Metrics Analysis
  • 5. Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics
  • 6. Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)
  • 7. Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)
  • 8. Growth Opportunity Analysis for Proteomics in Drug Discovery and Companion Diagnostics (continued)

9. METABOLOMICS SEGMENT BREAKDOWN

Metabolomics Segment Breakdown

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast discussion
  • 4. Revenue Forecast Discussion (continued)
  • 5. Metabolomics Segment-Metrics Analysis
  • 6. Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics
  • 7. Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics (continued)
  • 8. Growth Opportunity Analysis for Metabolomics in Drug Discovery and Companion Diagnostics (continued)

10. IMAGING SEGMENT BREAKDOWN

Imaging Segment Breakdown

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Imaging Segment-Metrics Analysis
  • 5. Growth Opportunity Analysis for Imaging in Drug Discovery and Companion Diagnostics
  • 6. Growth Opportunity Analysis for Imaging in Drug Discovery and Companion Diagnostics (continued)

11. BIOMARKER RESEARCH CLUSTERS

Biomarker Research Clusters

  • 1. UK Biobank
  • 2. UK Biobank (continued)
  • 3. UK Biobank (continued)
  • 4. UK Biobank (continued)
  • 5. UK Biobank (continued)
  • 6. The Biomarkers Consortium
  • 7. The Biomarkers Consortium (continued)
  • 8. The Biomarkers Consortium (continued)
  • 9. Other Biomarker Research Projects
  • 10. Other Biomarker Research Projects (continued)

12. REGIONAL ANALYSIS

Regional Analysis

  • 1. Market Attractiveness by Region
  • 2. Regional Analysis-The United Kingdom
  • 3. Regional Analysis-Germany
  • 4. Regional Analysis-France
  • 5. Regional Analysis-Italy
  • 6. Regional Analysis-Spain
  • 7. Regional Analysis-Benelux
  • 8. Regional Analysis-Scandinavia

13. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Aepodia S.A.
  • 2. Affymetrix
  • 3. Almac Group
  • 4. Argutus Medical Limited (EKF Diagnostics Group)
  • 5. AROS Applied Biotechnology A/S
  • 6. Bio-Rad Laboratories, Inc.
  • 7. BioSystems International
  • 8. Biovica International AB
  • 9. Diagenic ASA
  • 10. DNAVision SA
  • 11. Epigenomics AG
  • 12. Epistem Plc
  • 13. Eurofins Scientific
  • 14. Indivumed GmbH
  • 15. Metabometrix
  • 16. Pronota NV
  • 17. Protagen AG
  • 18. Proteome Sciences
  • 19. ProteoSys AG
  • 20. QIAGEN
  • 21. Roche
  • 22. Thermo Fisher Scientific

14. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. The Last Word-Discussion (continued)
  • 5. Legal Disclaimer

15. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Drivers Explained (continued)
  • 4. Restraints Explained
  • 5. Restraints Explained (continued)
  • 6. Restraints Explained (continued)
  • 7. List of Other Companies in Biomarkers Research, Development and/or Services
  • 8. List of Other Companies in Biomarkers Research, Development and/or Services (continued)
  • 9. List of Other Companies in Biomarkers Research, Development and/or Services (continued)
  • 10. Decision Support Database
  • 11. Decision Support Database (continued)
  • 12. Decision Support Database (continued)
  • 13. Additional Sources of Information on Diabetes
  • 14. Methodology
  • 15. Learn More-Next Steps
Back to Top